Screener Summaries Updates Institutions Sign In More Updates › Dividends & Buybacks › DXCM Dividends & Buybacks · May 15, 2026
Dexcom announced long-range financial targets during its 2026 Investor Day, projecting annual organic revenue growth… DXCM Dexcom Inc
Dexcom announced long-range financial targets during its 2026 Investor Day, projecting annual organic revenue growth of at least 10% through 2030 and 2030 non-GAAP margins for gross profit (67-69%), operating profit (29-30%), and adjusted EBITDA (36-37%). Additionally, the company's Board of Directors authorized a new share repurchase program of up to $1.0 billion, which is scheduled to conclude by June 30, 2027.
More from Dexcom Inc DexCom raises FY2026 revenue guidance to $5.20-$5.25B and authorizes $1.0 billion share buyback Oct 29, 2026 On September 10, 2026, the Board of Directors appointed Jereme Sylvain as Executive Vice President, Chief Operating… Sep 14, 2026 On September 10, 2026, DexCom, Inc. announced the appointment of Glenn S. Boehnlein to its Board of Directors… Sep 10, 2026 DexCom, Inc. reported second quarter 2026 financial results on July 30, 2026, announcing revenue of $1.308 billion, a… Jul 30, 2026 Dexcom, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected twelve directors and ratified… May 28, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
